Novel regulations of the angiotensin II receptor type 1 by calmodulin

被引:6
|
作者
Ehlers, Kevin [1 ]
Clements, Robert [1 ]
VerMeer, Mark [1 ]
Giles, Jennifer [1 ]
Tran, Quang-Kim [1 ]
机构
[1] Des Moines Univ, Osteopath Med Ctr, Dept Physiol & Pharmacol, 3200 Grand Ave,Ryan Hall 258, Des Moines, IA 50312 USA
基金
美国国家卫生研究院;
关键词
Angiotensin II receptor type 1; Calmodulin; Calcium; FRET biosensor; Angiotensin II; SMOOTH-MUSCLE-CELLS; PLASMA-MEMBRANE; BINDING; PROTEINS; NETWORK; PHOSPHORYLATION; INTERACTS; DOMAINS; SYSTEM; KINASE;
D O I
10.1016/j.bcp.2018.03.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The angiotensin II receptor type 1 (AT(1)R) mediates many Ca2+-dependent actions of angiotensin II (AngII). Calmodulin (CaM) is a key transducer of Ca2+ signals in cells. Two locations on the receptor's submembrane domains (SMD) 3 and 4 are known to interact with CaM. However, the binding sites for CaM, biochemical properties of the interactions, and their functional impact are not fully understood. Using a FRET-based screening method, we identified a new binding site for CaM on SMD2 (a.a. 125-141), in addition to SMD3 and the juxtamembranous region of SMD4 (SMD4(JM), a.a., 309-327). Simultaneous measurements of CaM binding and free Ca2+ show that the interactions are Ca2+-dependent, with disparate K-d and EC50(Ca2+) values within the physiological range of cytoplasmic Ca2+. Full interaction between CaM and SMD3 requires the entire domain (a.a. 215-242) and has an EC50(Ca2+) value in the range of resting cytoplasmic Ca2+, suggesting AT(1)R-CaM interaction can occur in resting conditions in cells. AngII induces robust ERK1/2 phosphorylation in primary vascular smooth muscle cells. This effect is suppressed by AT(1)R inhibitor losartan and virtually abolished by CaM antagonist W-7. AngII-induced ERK1/2 phosphorylation is suppressed in cells expressing mutant AT(1)R with reduced CaM binding at each identified binding domain. AngII triggers transient Ca2+ signals in cells expressing wild-type AT(1)R. These signals are reduced in cells expressing mutant AT(1)R with reduced CaM binding at SMD3 or SMD4(JM), but are very slow-rising, low amplitude signal in cells expressing AT(1)R. with reduced CaM binding at SMD2. The data indicate that CaM interactions with AT(1)R can occur at various domains, with different affinities, at different physiological Ca2+ levels, and are important for AT(1)R-mediated signaling.
引用
收藏
页码:187 / 200
页数:14
相关论文
共 50 条
  • [1] The Small GTPase Ral Couples the Angiotensin II Type 1 Receptor to the Activation of Phospholipase C-δ1
    Godin, Christina M.
    Ferreira, Lucimar T.
    Dale, Lianne B.
    Gros, Robert
    Cregan, Sean P.
    Ferguson, Stephen S. G.
    MOLECULAR PHARMACOLOGY, 2010, 77 (03) : 388 - 395
  • [2] Caveolae are essential for angiotensin II type 1 receptor-mediated ANP secretion
    Oh, Young-Bin
    Gao, Shan
    Lim, Jung Min
    Kim, Hyung Tae
    Park, Byung-Hyun
    Kim, Suhn Hee
    PEPTIDES, 2011, 32 (07) : 1422 - 1430
  • [3] Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor-Mediated Cardiomyocyte Autophagy
    Porrello, Enzo R.
    D'Amore, Angelo
    Curl, Claire L.
    Allen, Andrew M.
    Harrap, Stephen B.
    Thomas, Walter G.
    Delbridge, Lea M. D.
    HYPERTENSION, 2009, 53 (06) : 1032 - 1040
  • [4] Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist
    Fujimoto, Y
    Sasaki, T
    Tsuchida, A
    Chayama, K
    FEBS LETTERS, 2001, 495 (03) : 197 - 200
  • [5] Attenuation of inflammatory vascular remodeling by angiotensin II type 1 receptor-associated protein
    Oshita, Akira
    Iwai, Masaru
    Chen, Rui
    Ide, Ayumi
    Okumura, Midori
    Fukunaga, Shiori
    Yoshii, Toyofumi
    Mogi, Masaki
    Higaki, Jitsuo
    Horiuchi, Masatsugu
    HYPERTENSION, 2006, 48 (04) : 671 - 676
  • [6] Biased Agonism of the Angiotensin II Type 1 Receptor
    Godin, C. M.
    Ferguson, S. S. G.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 812 - 816
  • [7] Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent
    Yang, Rui
    Smolders, Ilse
    Vanderheyden, Patrick
    Demaegdt, Heidi
    Van Eeckhaut, Ann
    Vauquelin, Georges
    Lukaszuk, Aneta
    Tourwe, Dirk
    Chai, Siew Yeen
    Albiston, Anthony L.
    Nahmias, Clara
    Walther, Thomas
    Dupont, Alain G.
    HYPERTENSION, 2011, 57 (05) : 956 - U186
  • [8] Apelin Receptor is an Allosteric Inhibitor of the Angiotensin II Type 1 Receptor
    Smith, Layton H.
    Siddiquee, Khandaker
    Hampton, Jessica
    CIRCULATION, 2011, 124 (21)
  • [9] Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II
    Miller, JA
    Thai, K
    Scholey, JW
    KIDNEY INTERNATIONAL, 1999, 56 (06) : 2173 - 2180
  • [10] Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats
    Wenzel, Katrin
    Rajakumar, Augustine
    Haase, Hannelore
    Geusens, Nele
    Hubner, Norbert
    Schulz, Herbert
    Brewer, Justin
    Roberts, Lyndsay
    Hubel, Carl A.
    Herse, Florian
    Hering, Lydia
    Qadri, Fatimunnisa
    Lindschau, Carsten
    Wallukat, Gerd
    Pijnenborg, Robert
    Heidecke, Harald
    Riemekasten, Gabriela
    Luft, Friedrich C.
    Muller, Dominik N.
    Lamarca, Babette
    Dechend, Ralf
    HYPERTENSION, 2011, 58 (01) : 77 - 84